Status not kept up to date
Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT03010553 · Gustave Roussy, Cancer Campus, Grand Paris · Updated 5 Jan 2017
- What is being tested
- Detection and resection of sentinel lymph node
- For
- Head and Neck Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 100 people. The full rules are on the registry page.
- Where
- France
- When
- Starts or started Feb 2008, ends Dec 2017. Registered 5 Jan 2017.
- Results
- None posted yet.
In the researchers' words
Fifty patients with squamous cell carcinoma of the larynx T1 or T2N0 will therefore have a 99mTc lymphoscintigraphy per operative. The identified sentinel node will be removed along with the other lymph nodes of the selective group II and III recess. Sentinel lymph node staging alone and complete dissection with routine anatomical pathology will be compared If this technique is reliable it will make a therapeutic de-escalation in the treatment of small tumors of the larynx by limiting the ganglionic gesture in the patients whose sentinel node is free from metastasis and also to better choose the treatment in case of lymph node involvement
Sites
- Gustave RoussyVillejuif, Val de Marne, France